SK3 Group Inc. announced that it has obtained licenses for several proprietary technologies for the extraction, purification, and creation of medicines consisting of cannabinoids from hemp and marijuana. The medicinal products covered by this license include: High-CBD cannabis tinctures, capsules and edibles, a sublingual spray, and infused vegetable oils. Medical Greens will oversee quality control and provide testing for cannabinoid content and microbiological purity.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.24K | |
+6.13% | 7.41B | |
-32.64% | 3.24B | |
+11.38% | 1.75B | |
-9.32% | 1.08B | |
+31.69% | 907M | |
-7.64% | 714M | |
-3.60% | 606M | |
-8.30% | 539M | |
-22.29% | 515M |
- Stock Market
- Equities
- SKTO Stock
- News SK3 Group, Inc.
- SK3 Group Secures CBD Extraction and Purification Technology License